4.2 Article

A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder

Journal

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Volume 22, Issue 4, Pages 460-463

Publisher

WILEY
DOI: 10.1111/jns.12235

Keywords

autism spectrum disorder; KIF1A; Kinesin family member 1A gene; next-generation sequencing; peripheral neuropathy

Funding

  1. Medical Research Council (MRC)
  2. MRC Centre grant [G0601943]
  3. National Institutes of Neurological Diseases and Stroke
  4. office of Rare Diseases [U54NS065712]
  5. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  6. National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London
  7. Brazilian National Council for Scientific and Technological Development (CNPq)
  8. Wellcome Trust [110043/Z/15/Z]
  9. Wellcome Trust [110043/Z/15/Z] Funding Source: Wellcome Trust
  10. Medical Research Council [G0601943] Funding Source: researchfish
  11. Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish
  12. National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish
  13. Wellcome Trust [110043/Z/15/Z] Funding Source: researchfish
  14. MRC [G0601943] Funding Source: UKRI

Ask authors/readers for more resources

Mutations in the kinesin family member 1A (KIF1A) gene have been associated with a wide range of phenotypes including recessive mutations causing hereditary sensory neuropathy and hereditary spastic paraplegia and de novo dominant mutations causing a more complex neurological disorder affecting both the central and peripheral nervous system. We identified by exome sequencing a de novo dominant missense variant, (c.38G>A, p.R13H), within an ATP binding site of the kinesin motor domain in a patient manifesting a complex phenotype characterized by autism spectrum disorder (ASD), spastic paraplegia and axonal neuropathy. The presence of ASD distinguishes this case from previously reported patients with de novo dominant mutations in KIF1A.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available